Ionis Pharmaceuticals, Inc. revenue for the last year amounted to 788.00 M USD, the most of which — 787.65 M USD — came from its highest performing source at the moment, Human Therapeutic Medicines, the year earlier bringing 587.37 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought Ionis Pharmaceuticals, Inc. 787.65 M USD, and the year before that — 587.37 M USD.